[ESPR] QoQ Quarter Result on 30-Sep-2002 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
29-Sep-2002
Financial Year
2002
Quarter
30-Sep-2002 [#Q3]
Profit Trend
QoQ- 10.79%
YoY- -11.13%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -8,435 -7,406 -6,619 -6,980 -7,824 -7,303 -6,344 20.97%
Tax 922 633 692 177 888 314 -112 -
NP -8,435 -7,406 -6,619 -6,980 -7,824 -7,303 -6,344 20.97%
Tax Rate - - - - - - - -
Total Cost 8,435 7,406 6,619 6,980 7,824 7,303 6,344 20.97%
Ratio Analysis
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
EPS -2.00 -1.76 -1.58 -1.67 -1.87 -1.75 -1.57 17.56%
EPS Diluted -2.00 -1.76 -1.58 -1.67 -1.87 -1.75 -1.57 17.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.